Quick Facts
| Property | Details |
|---|---|
| What it is | Extract from the fruit of Vaccinium macrocarpon, the North American cranberry |
| Key Compounds | A-type proanthocyanidins (PACs), anthocyanins, flavonols, organic acids |
| Primary Benefits | UTI prevention through bacterial anti-adhesion, antioxidant activity, cardiovascular support |
| Standard Dose | 500-1500 mg/day standardized extract delivering 36-72 mg PAC |
| Best Time to Take | Split morning and evening with meals |
| Form | Capsule, tablet, powder, or juice (unsweetened) |
| Evidence Grade | B (Strong Cochrane evidence for UTI prevention, emerging cardiovascular data) |
| Critical Safety Note | May interact with warfarin at high doses. GI upset possible with juice on empty stomach. |
Cranberry is one of the few supplements with consistent clinical trial evidence behind a single, specific health claim: preventing recurrent urinary tract infections. The 2023 Cochrane review analyzed 50 trials and found that cranberry products reduced UTI risk by approximately 25% in women prone to recurrent infections (Williams et al., 2023).
Beyond UTI prevention, newer research has explored cranberry’s effects on cardiovascular risk markers, inflammation, and gut health. The evidence for these secondary uses is less developed but shows promising early signals. Below is a full breakdown of what cranberry does, how it works, the research behind it, and practical dosing guidance.
How Cranberry Works
The Anti-Adhesion Mechanism
Cranberry’s UTI-preventive effect is not about killing bacteria. Instead, its A-type proanthocyanidins (PACs) physically block uropathogenic E. coli from adhering to the epithelial cells lining the urinary tract. Without adhesion, the bacteria cannot colonize and are flushed out during normal urination.
Howell et al. (2024) demonstrated that cranberry PACs specifically inhibit both P-fimbriated and Type 1 fimbriated E. coli strains, the two most common pathogenic types in urinary infections (Howell et al., 2024). This anti-adhesion activity is unique to A-type PAC linkages found in cranberry and is not replicated by the B-type PACs found in most other fruits like grape or apple (Howell et al., 2015).
Neto et al. (2017) further characterized cranberry constituents and found that non-dialyzable cranberry material inhibited bacterial adhesion, co-aggregation, and biofilm formation, suggesting multiple pathways through which cranberry disrupts bacterial colonization (Neto et al., 2017).
Antioxidant Compounds
Cranberry contains a dense profile of polyphenols beyond PACs. These include anthocyanins (the red pigments), quercetin, myricetin, and phenolic acids. A 2022 review by Nemzer et al. cataloged the antioxidant compounds in cranberry and documented their capacity to neutralize reactive oxygen species and inhibit lipid peroxidation (Nemzer et al., 2022).
Key Benefits
UTI Prevention
This is cranberry’s strongest evidence base. The 2023 Cochrane review by Williams et al. included 50 randomized controlled trials with over 8,800 participants. The review concluded that cranberry products reduced the risk of symptomatic, culture-confirmed UTIs by about 25% in women with recurrent infections, by 54% in children, and showed a non-significant trend toward benefit in older adults (Williams et al., 2023).
The earlier 2012 Cochrane review by Jepson et al. had been more cautious in its conclusions, largely due to high dropout rates in many trials and inconsistent product standardization (Jepson et al., 2012). The updated 2023 review, with 26 new trials, shifted the evidence toward a clearer benefit.
A 2025 multicenter RCT by Stonehouse et al. reinforced these findings. Women with a history of recurrent UTIs who took a whole cranberry fruit powder supplement daily for 6 months had significantly fewer culture-confirmed UTIs than the placebo group (Stonehouse et al., 2025).
A meta-analysis by Xia et al. (2021) pooling data from susceptible populations confirmed that cranberry consumption, as an adjuvant alongside standard care, significantly reduced UTI recurrence (Xia et al., 2021).
Cardiovascular Support
Emerging evidence suggests cranberry supplementation may benefit cardiovascular health markers. A 2024 meta-analysis by Delpino et al. found that cranberry and blueberry supplementation reduced blood pressure in patients with cardiovascular risk factors (Delpino et al., 2024).
A 2024 clinical study by de Souza Gouveia Moreira et al. found that cranberry extract supplementation reduced lipid peroxidation and inflammatory markers in participants with metabolic risk factors (de Souza Gouveia Moreira et al., 2024).
These cardiovascular findings are preliminary compared to the UTI evidence, but they align with the broader literature on polyphenol-rich fruit extracts and vascular health.
Antioxidant and Anti-Inflammatory Activity
Cranberry polyphenols demonstrate antioxidant and anti-inflammatory activity in both in vitro and human studies. González de Llano et al. (2020) reviewed the mechanisms by which cranberry polyphenols modulate inflammatory pathways and oxidative stress markers in the urinary tract and beyond (González de Llano et al., 2020).
Dosage
The critical dosing factor for cranberry is not total milligrams of cranberry extract but rather the amount of A-type proanthocyanidins (PAC) delivered. Products standardized to PAC content show more consistent results in clinical trials than unstandardized juice or extract.
For UTI prevention:
- 36 mg PAC/day is the minimum threshold supported by clinical evidence
- 72 mg PAC/day is used in higher-dose protocols and some positive RCTs
- This typically translates to 500-1500 mg of standardized cranberry extract per day, depending on PAC concentration
For general antioxidant support:
- 500 mg/day of standardized extract is a reasonable starting point
Cranberry juice: Unsweetened cranberry juice can provide PACs, but the amounts per serving are inconsistent and added sugar in most commercial juice products offsets potential benefits. Capsule or powder extracts with standardized PAC content are preferred for reliable dosing.
Timing: Split dosing (morning and evening) maintains more consistent urinary PAC levels throughout the day. Ledda et al. (2017) showed that a standardized cranberry extract taken twice daily provided effective UTI prophylaxis in young healthy women (Ledda et al., 2017).
Safety and Side Effects
Cranberry supplements have an excellent safety profile at standard doses. The most common side effect is mild gastrointestinal discomfort, particularly with juice consumed on an empty stomach.
Warfarin Interaction
The most clinically relevant safety concern involves cranberry’s potential interaction with warfarin. Tan et al. (2021) conducted a systematic review of warfarin interactions with food and herbal supplements and found case reports of INR elevation with concurrent high-dose cranberry juice consumption (Tan et al., 2021). Anyone taking warfarin or other anticoagulants should consult their healthcare provider before adding cranberry supplements.
Pregnancy
Dugoua et al. (2008) reviewed the safety and efficacy of cranberry during pregnancy and lactation and found no evidence of harm at standard supplemental doses (Dugoua et al., 2008). Pregnant women with recurrent UTIs should still consult a healthcare provider before supplementing.
Kidney Stones
High-dose cranberry supplementation may increase urinary oxalate excretion, which could theoretically raise risk of calcium oxalate kidney stones in susceptible individuals. At standard PAC-based doses (36-72 mg PAC/day), this concern is minimal. People with a history of oxalate kidney stones should exercise caution with very high doses or large volumes of cranberry juice.
How to Choose a Cranberry Supplement
Look for PAC standardization. Products should list A-type proanthocyanidin content per serving, not just total cranberry extract weight. Without PAC standardization, you cannot verify whether the product delivers a clinically relevant dose.
Avoid added sugar. Cranberry juice cocktails often contain more sugar than actual cranberry. If using juice, choose unsweetened varieties.
Check the extract type. Whole cranberry fruit powder, as used in the 2025 Stonehouse RCT, showed positive results. Concentrated extracts standardized to PAC content have the most consistent evidence.
Related Ingredients
- D-Mannose, another urinary tract health supplement that works through a different anti-adhesion mechanism
- Vitamin C, sometimes combined with cranberry for urinary acidification
References
- Williams G et al. (2023). Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. PMID: 37947276
- Jepson RG et al. (2012). Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. PMID: 23076891
- Stonehouse W et al. (2025). Whole cranberry fruit powder supplement reduces UTI incidence. Am J Clin Nutr. PMID: 39863114
- Howell AB et al. (2024). Cranberry urinary anti-adhesion activity. J Diet Suppl. PMID: 38804849
- Howell A et al. (2015). Comparison of anti-adhesion activity of cranberry extracts. Nat Prod Commun. PMID: 26411014
- Neto CC et al. (2017). Cranberry constituents inhibit adhesion and biofilm formation. Food Funct. PMID: 28470309
- Nemzer BV et al. (2022). Cranberry: composition, antioxidant activity, and health impact. Molecules. PMID: 35268605
- González de Llano D et al. (2020). Cranberry polyphenols and UTI prevention. Molecules. PMID: 32752183
- Xia JY et al. (2021). Cranberry adjuvant therapy for UTI in susceptible populations. PLoS One. PMID: 34473789
- Delpino FM et al. (2024). Cranberry supplementation on blood pressure. Phytother Res. PMID: 37963472
- de Souza Gouveia Moreira L et al. (2024). Cranberry extract on lipid peroxidation and inflammation. J Nutr Metab. PMID: 38752013
- Ledda A et al. (2017). Cranberry extract prophylaxis in young healthy subjects. Eur Rev Med Pharmacol Sci. PMID: 28165546
- Tan CSS et al. (2021). Warfarin and food, herbal or dietary supplement interactions. Br J Clin Pharmacol. PMID: 32478963
- Dugoua JJ et al. (2008). Safety of cranberry during pregnancy and lactation. Can J Clin Pharmacol. PMID: 18204103